Polyarteritis Nodosa and Churg-Strauss Syndrome an Internist’s View

  • L. Guillevin
  • M. Gayraud
  • Ph. Casassus
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 336)


Vasculitides of the polyarteritis nodosa group and Wegener’s granulomatosis are rare diseases and determination of the optimal diagnostic investigations and treatment is difficult. Over the past decade, we have observed and treated 143 vasculitis patients in our Department of Internal Medicine and have also carried out several prospective trials 1,2,3 which have included 300 patients. Our presentation is based on these results.


Plasma Exchange Polyarteritis Nodosa Antineutrophil Cytoplasm Antibody 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    L. Guillevin, B. Jarrousse, C. Lok, F. Lhote, Ph. Jais, T.D.H. Le, and A. Bussel. Long-term follow-up after treatment of polyarteritis nodosa and Churg-Strauss angiitis with comparison of steroids, plasma exchange and cyclophosphamide to steroids and plasma exchange. A prospective randomized trial of 71 patients J. Rheumatol., 18: 576–584, 1991Google Scholar
  2. 2.
    L. Guillevin, O. Fain, F. Lhote, B. Jarrousse, L.T.H. Du, A. Bussel and A. Leon A lack of superiority of steroid plus plasma exchange to steroids alone in the treatment of polyarteritis nodosa and Churg Strauss syndrome Arthritis Rheum., 35: 208–214, 1992Google Scholar
  3. 3.
    L. Guillevin, F. Lhote, A. Leon, F. Fauvelle, L. Vivitski, C. Trepo Treatment of polyarteritis nodosa related to hepatitis B virus with short-term steroid therapy associated with antiviral agents and plasma exchanges. a prospective trial in 33 patients. J. Rheumatol. 1993 (in press)Google Scholar
  4. 4.
    R.W. Jr Lightfoot, B.A. Michel, D.A. Bloch, G.G. Hunder, N.J. Zvaifler, D.J. McShane, W.P. Arend, L.H. Calabrese, R.Y. Leavitt, T.J. Lie, A.T. Masi, J.A. Mills, M.B. Stevens, S.L Wallace The American College of Rheumatology 1990: criteria for the classification of polyarteritis nodosa Arthritis Rheum., 33: 1088–1093, 1990Google Scholar
  5. 5.
    A.T. Masi, G.G. Hunder, J.T. Lie and al The American College of Rheumatology 1990: criteria for the classification of Churg-Strauss syndrome (allergic granulomatosis and angiitis) Arthritis Rheum., 33: 1094–1100, 1990Google Scholar
  6. 6.
    P.P. Frohnert, S.G. S.eps Long-term follow-up study of periarteritis nodosa Am. J. Med., 43: 8–14, 1967Google Scholar
  7. 7.
    E.S. Leib, C. Restivo and H.E. Paulus Immunosuppressive and corticosteroid therapy of polyarteritis nodosa Am. J. Med., 67: 941–947, 1979CrossRefGoogle Scholar
  8. 8.
    A.S Fauci, P. Katz and B.F. Haynes, S. M. Wolff Cyclophosphamide therapy of severe necrotizing vasculitis N. Engl. J. Med., 301: 3235–238, 1979Google Scholar
  9. 9.
    R.D. Cohen, D.L. Conn, D.M.Ilstrup Clinical features, prognosis, and response to treatment of polyarteritis Mayo Clin. Proc., 55: 146–155, 1980Google Scholar
  10. 10.
    L. Guillevin, T.H.D. Le, P. Godeau, J. Ph. Jais, B. Wechler Clinical findings and prognosis of polyarteritis nodosa and Churg Strauss Angiitis: a study in 165 patients Brit. J. Rheumatol., 27: 258–264, 1988CrossRefGoogle Scholar
  11. 11.
    O. Bletry, A. Bussel, I. Badelon, L. Guillevin, P. Lesavre, S. Herson, P. Godeau Interêt des échanges plasmatiques au cours des angeites nécrosantes. Onze cas Nouv Presse Med., 11: 2827–2832, 1982Google Scholar
  12. 12.
    C.M. Lockwood, S. Worledge, A. Nicholas, C. Cotton, D. K. Peters Reversal of impaired splenic function in patients with nephritis or vasculitis (or both) by plasma exchange N. Engl. J. Med., 300: 524–530, 1979PubMedCrossRefGoogle Scholar
  13. 13.
    J.M. Chalopin, G. Rifle, J.M. Turc, P. Cortet, M. Severac Immunological findings during successful treatment of Hbs Ag-associated polyarteritis nodosa by plasmapheresis alone Brit. M.d. J., 1980, 1, 368Google Scholar
  14. 14.
    L. Guillevin, Y. Tanter, O. Bletry, J. M. Chalopin, C. Lok, G. Andreu, G. Rifle, P. Godeau Treatment of severe polyarteritis nodosa with plasma exchange Prog Artif Organs, edited by K Atsumi, M Maekawa, K Ota, Cleveland, ISAO Press, 723–726, 1983Google Scholar
  15. 15.
    R. Peto, M.C. Pike, P. Armitage Design and analysis of randomized clinical trials requiring prolonged observations of each patient. II. Analysis and examples. Brit. J. Cancer, 35: 1–19, 1977CrossRefGoogle Scholar
  16. 16.
    Cox DR Regression models and life tables J. R. Stat. Soc., 34: 187–219, 1972Google Scholar
  17. 17.
    C.O.C. Savage, C.G. Winearls, S. Jones and al. Prospective study of radioimmunoassay for antibodies against neutrophil cytoplasm in diagnosis of systemic vasculitis Lancet, 1: 1389–1393, 1987PubMedCrossRefGoogle Scholar
  18. 18.
    J.W. Cohen-Tervaert, M.G. Huitema Prevention of relapses in Wegener’s granulomatosis by treatment based on antineutrophil cytoplasmic antibody titre Lancet, 2: 709–711, 1990CrossRefGoogle Scholar
  19. 19.
    R.J. Falk, J.C. Jennette Antineutrophil cytoplasmic antibodies with specificity for myeloperoxydase in patients with systemic vasculitis and idiopathic and crescentic glomerulonephritis. N Engl J Med, 318: 1651–1657, 1988PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1993

Authors and Affiliations

  • L. Guillevin
    • 1
    • 2
  • M. Gayraud
    • 1
    • 2
  • Ph. Casassus
    • 1
    • 2
  1. 1.Department of Internal Medicine, Hôpital AvicenneUniversité Paris-NordBobignyFrance
  2. 2.INSERM U 21VillejuifFrance

Personalised recommendations